|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.34 USD | -2.25% |
|
-8.05% | +161.45% |
| Apr. 09 | Transcript : ADC Therapeutics SA - Special Call | |
| Apr. 04 | Sector Update: Health Care Stocks Slump Late Afternoon | MT |
ADC Therapeutics SA reported earnings results for the fourth quarter ended December 31, 2023. For the fourth quarter, the company reported revenue was USD 16.79 million compared to USD 69.8 million a year ago. Net loss was USD 85.03 million compared to USD 23.34 million a year ago.
Basic loss per share from continuing operations was USD 1.03 compared to USD 0.29 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +161.45% | 358M | |
| -2.31% | 103B | |
| +0.56% | 95.28B | |
| +1.69% | 22.15B | |
| -17.37% | 21.02B | |
| -9.30% | 18.15B | |
| -41.01% | 16.74B | |
| -14.85% | 16.05B | |
| +3.21% | 13.68B | |
| +33.54% | 12.17B |
ADC THERAPEUTICS SA 
